Business Context and Reporting Period
This Form 6-K filing by Alps Global Holding Pubco (soon to be renamed Alps Group Inc.) covers the period ending October 10, 2025. The filing reports on the successful stockholder approval of a business combination between Globalink Investment Inc. and Alps Life Sciences Inc. The transaction involves a two-step merger: a redomestication of Globalink into PubCo and the acquisition of Alps by a PubCo subsidiary. The closing of the business combination is expected on or around October 15, 2025.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels for the reporting period. The document focuses exclusively on corporate governance actions and transaction mechanics. Key capital structure details include:
- Share Redemption: 59,966 public shares were redeemed for cash.
- Remaining Public Shares: 12,635 public shares remain outstanding following redemptions.
- Share Capital Restructuring: PubCo's share capital will be restructured to include 495,000,000 ordinary shares and 5,000,000 preferred shares.
- Exchange Ratio: Upon closing, Alps Holdco shares will be cancelled in exchange for approximately 2.76 PubCo ordinary shares per Alps Holdco share.
- Maximum Issuance: The transaction may result in the issuance of up to 160,000,000 PubCo ordinary shares.
Material Changes Versus Prior Period
The primary material change is the definitive approval of the business combination, which alters the company's corporate structure and name. Specifically:
- Corporate Name: PubCo will change its name to Alps Group Inc.
- Charter Amendment: The limitation requiring net tangible assets of at least $5,000,001 upon consummation of a business combination has been eliminated from the Globalink Charter.
- Ownership Structure: Alps will become a wholly-owned subsidiary of the surviving PubCo entity.
Guidance, Outlook, and Risks
Outlook and Closing: Management expects the business combination to close on or around October 15, 2025. The transaction is contingent upon the completion of the approved steps, including the redomestication and acquisition mergers.
Voting Results: Stockholder approval was unanimous for the key proposals. At the Special Meeting on October 7, 2025, 3,445,007 shares voted "For" and 0 votes were cast "Against" or "Abstained" for the Redomestication Merger, Acquisition Merger, and Charter Amendment proposals.
Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond the standard requirement for the transaction to close following the approved votes and regulatory steps.
Important Facts for Investor Verification
- Verify the final closing date of the business combination, currently expected around October 15, 2025.
- Confirm the final share count and capitalization structure post-closing, specifically the issuance of up to 160,000,000 new ordinary shares.
- Review the definitive proxy statement/prospectus filed on September 17, 2025, for detailed terms of the merger consideration and financial projections.
- Monitor the official name change from Alps Global Holding Pubco to Alps Group Inc. upon closing.